News About: Goverment
Restriction targets cold medicine
The government plans to restrict sales of cold medications containing a substance often used in the illegal manufacture of methamphetamine, according to the Korea Food and Drug Administration.
Pseudoephedrine, a ma...
Health insurance covers 10 medicines only since introduction of positive list system
The government has asked the national health insurance to cover 10 medicines to reduce snowballing medication costs since implementation of the positive list system, triggering mounting concerns among drug makers.
...
Government mulls earlier implementation of pharmacy college’s six-year course plan
The government is considering implementing pharmacy college’s six-year courses from 2010, one year earlier than original plan, according to the Ministry of Education, Science and Technology.
“We are now under consu...
KFDA approves Ahngook’s cough medicine
Ahngook says the Korea Food and Drug Administration has approved its cough medicine theobromine 300 mg capsule (trade name: Anycough).
A cough medicine is a medicinal drug used to treat coughing and related conditi...
KFDA sends GMP officials to U.S.
The Korea Food and Drug Administration said it dispatch its GMP inspectors to check whether a new AIDS medicine of Merck and Company of the United States conforms to Korea’s GMP standards.
The KFDA inspectors will ...
Government to raise amino acid infusion prices
The government plans to raise essential Ringer’s solutions by about 88 percent in the latter half of this year.
However, domestic three drug makers for essential amino infusion Choongwae Pharm, CJ Corporation and D...
KFDA’s regional agencies to be disbanded
The six regional agencies of the Korea Food and Drug Administration will be disbanded, and government work related to the drug and medical device industries are likely to be integrated under the central KFDA.
The s...
Civic groups back government’s evaluation plan
Local five civic groups said that the government should push up with its plan to evaluate the economic effectiveness of conventional medicines between 2007 and 2011 and gradually readjust prices and exclude items that...
Government’s new drug pricing policy to meet backlash
After the Health Insurance Review Agency unveiled its assessment results of lipid-lowering agents last week, the agency is likely to meet backlash from the domestic pharmaceutical industry.
The nation’s two busines...
Government urged to promote guide- and field-oriented administrationThe Korea Food and Drug Administration needs to work out measures to encourage local pharmaceutical firms through guide- and field-oriented administration as deregulation effort...
|
